# TA-8995: Its Use in Patients With Mild Dyslipidaemia (TULIP)

> **NCT01970215** · PHASE2 · COMPLETED · sponsor: **Xention Ltd** · enrollment: 364 (actual)

## Conditions studied

- Dyslipidemia

## Interventions

- **DRUG:** TA-8995
- **DRUG:** Atorvastatin
- **DRUG:** Rosuvastatin
- **DRUG:** TA-8995 0mg (placebo)
- **DRUG:** Placebo Statin

## Key facts

- **NCT ID:** NCT01970215
- **Lead sponsor:** Xention Ltd
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-08
- **Primary completion:** 2014-07
- **Final completion:** 2014-07
- **Target enrollment:** 364 (ACTUAL)
- **Last updated:** 2014-08-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01970215

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01970215, "TA-8995: Its Use in Patients With Mild Dyslipidaemia (TULIP)". Retrieved via AI Analytics 2026-07-25 from https://api.ai-analytics.org/clinical/NCT01970215. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*